Kayne Anderson Rudnick Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.35M | Sell |
12,013
-221
| -2% | -$98.4K | 0.01% | 258 |
|
|
2025
Q1 | $5.93M | Sell |
12,234
-40
| -0.3% | -$19.4K | 0.01% | 260 |
|
|
2024
Q4 | $4.94M | Sell |
12,274
-827
| -6% | -$333K | 0.01% | 267 |
|
|
2024
Q3 | $6.09M | Sell |
13,101
-325
| -2% | -$151K | 0.01% | 262 |
|
|
2024
Q2 | $6.29M | Sell |
13,426
-293
| -2% | -$137K | 0.02% | 268 |
|
|
2024
Q1 | $5.73M | Sell |
13,719
-483
| -3% | -$202K | 0.01% | 281 |
|
|
2023
Q4 | $5.78M | Sell |
14,202
-561
| -4% | -$228K | 0.01% | 279 |
|
|
2023
Q3 | $5.13M | Sell |
14,763
-111
| -0.7% | -$38.6K | 0.01% | 286 |
|
|
2023
Q2 | $5.23M | Sell |
14,874
-223
| -1% | -$78.5K | 0.01% | 288 |
|
|
2023
Q1 | $4.76M | Buy |
15,097
+4
| +0% | +$1.26K | 0.01% | 295 |
|
|
2022
Q4 | $4.36M | Sell |
15,093
-639
| -4% | -$185K | 0.01% | 305 |
|
|
2022
Q3 | $4.56M | Buy |
15,732
+15,722
| +157,220% | +$4.55M | 0.02% | 290 |
|
|
2022
Q2 | $3K | Sell |
10
-26
| -72% | -$7.8K | ﹤0.01% | 577 |
|
|
2022
Q1 | $9K | Buy |
36
+26
| +260% | +$6.5K | ﹤0.01% | 541 |
|
|
2021
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 592 |
|
|
2021
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 559 |
|
|
2021
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 550 |
|
|
2021
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 546 |
|
|
2020
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 557 |
|
|
2020
Q3 | $3K | Sell |
10
-17
| -63% | -$5.1K | ﹤0.01% | 497 |
|
|
2020
Q2 | $8K | Hold |
27
| – | – | ﹤0.01% | 444 |
|
|
2020
Q1 | $6K | Hold |
27
| – | – | ﹤0.01% | 451 |
|
|
2019
Q4 | $6K | Buy |
27
+10
| +59% | +$2.22K | ﹤0.01% | 449 |
|
|
2019
Q3 | $3K | Hold |
17
| – | – | ﹤0.01% | 489 |
|
|
2019
Q2 | $3K | Buy |
+17
| New | +$3K | ﹤0.01% | 484 |
|